The 94.5% market-implied probability of no new coronavirus pandemic in 2026 rests on CDC and WHO surveillance confirming SARS-CoV-2 circulation at endemic levels, with reproduction numbers (Rt) below 1 in most U.S. states as of mid-May and test positivity rates near 2%. Ongoing genomic sequencing shows only Omicron sublineages such as XFG.1.1 dominating, none meeting variant-of-concern criteria for sustained exponential growth or elevated severity. High population immunity from prior infections and vaccination continues to limit transmission potential, while no novel coronaviruses have triggered WHO public-health emergency thresholds or widespread zoonotic spillovers. Key upcoming data releases from weekly wastewater monitoring and variant assessments through summer 2026 could shift sentiment if a new strain demonstrates rapid immune escape or efficient human-to-human spread.